Skip to main content

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Carlos Molina Cateriano

Institutions of which they are part

Head of group
Stroke research
Vall Hebron Institut de Recerca

Projects

Impacto de la evaluación neurovascular y determinación de biomarcadores en el diagnóstico pre-hospitalario del ictus hiperagudo

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Anna Penalba Morenilla, Maria Pilar Meler Amella
Funding agency: Instituto de Salud Carlos III
Funding: 108075.99
Reference: PI11/01677
Duration: 01/01/2012 - 31/12/2014

European Stroke Research Network for Hypothermia (EUROHYP-1) Grant Agreement nº 278709

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Estela Sanjuan Menendez, Marc Ribó Jacobi, Maria Pilar Meler Amella, David Rodriguez Luna, Mª Ángeles Muchada López
Funding agency: EUROPEAN COMMISSION
Funding: 655474
Reference: 'EUROHYP-1_FP7HEALTH2011
Duration: 01/02/2012 - 31/07/2018

European Stroke Research Network

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Carlos Molina Cateriano, Anna Rosell Novel
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 97000
Reference: EUS2008-03610
Duration: 01/01/2009 - 28/02/2013

Ministerio de Ciencia

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 46800
Reference: 2009 SGR 432
Duration: 01/01/2010 - 30/04/2014

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Edoardo Caronna

Edoardo Caronna

Postdoctoral researcher
Headache and Neurological Pain
Read more
Selen Ozkan

Selen Ozkan

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Pediatric Neurology
Read more
Tamara Garcia Antolinez

Tamara Garcia Antolinez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.